標題: Titlebook: Breast Cancer Biology for the Radiation Oncologist; Jonathan Strauss,William Small,Gayle E. Woloschak Book 2015 Springer-Verlag Berlin Hei [打印本頁] 作者: FERN 時間: 2025-3-21 17:58
書目名稱Breast Cancer Biology for the Radiation Oncologist影響因子(影響力)
書目名稱Breast Cancer Biology for the Radiation Oncologist影響因子(影響力)學科排名
書目名稱Breast Cancer Biology for the Radiation Oncologist網(wǎng)絡公開度
書目名稱Breast Cancer Biology for the Radiation Oncologist網(wǎng)絡公開度學科排名
書目名稱Breast Cancer Biology for the Radiation Oncologist被引頻次
書目名稱Breast Cancer Biology for the Radiation Oncologist被引頻次學科排名
書目名稱Breast Cancer Biology for the Radiation Oncologist年度引用
書目名稱Breast Cancer Biology for the Radiation Oncologist年度引用學科排名
書目名稱Breast Cancer Biology for the Radiation Oncologist讀者反饋
書目名稱Breast Cancer Biology for the Radiation Oncologist讀者反饋學科排名
作者: 艦旗 時間: 2025-3-21 21:20 作者: Desert 時間: 2025-3-22 00:24
Current Clinical Role of Genetic Profiling in Breast Cancer, Several genetic profile assays are already commercially available, and others are being developed and tested. OncotypeDx, a 21-gene assay, and MammaPrint, a 70-gene assay are the most extensively evaluated tests. Currently, three prospective trials to assess the predictive value of gene signature a作者: BADGE 時間: 2025-3-22 05:36 作者: glowing 時間: 2025-3-22 10:27
Cancer Stem Cells and Radiotherapy,lation due to radiation described decades ago is being supported by new experimental data. The heterogeneity of cancer cell populations in a given tumor is recently evidenced by the present of cancer stem cells (CSCs) that are different from other non-CSC tumor cells and maintain unique self-renewal作者: 巧辦法 時間: 2025-3-22 14:58 作者: 隱藏 時間: 2025-3-22 21:01
Genetic Syndromes and Radiotherapy in Breast Cancer,ely recent identification of the BRCA1 and BRCA2 genes in the mid-1990s, the expense associated with testing, and the inherent selection biases, the available literature has inherent limitations with relatively small patient numbers and lack of prospective randomized trials in this subset of patient作者: 神經(jīng) 時間: 2025-3-23 00:08
Experimental Therapies in Breast Cancer,therapy is designed to maximize therapeutic potential while minimizing harm to surrounding healthy tissue. Recently, advances in material design, synthesis, and characterization have lead to a surge in the number of approaches intended to shrink or eliminate the tumor burden of breast cancer. These 作者: 絕緣 時間: 2025-3-23 01:55
A Volatile Mix of Business and Politicsthat the candidate gene approach is inadequate to discover clinically useful indicators of radiation sensitivity. Genome-wide association studies (GWAS) and international collaborations may hold the key to future progress in this area.作者: endocardium 時間: 2025-3-23 05:49
From Outcast to Presidential Premiers in molecular-based and gene-based targeting, intralesional and intraoperative designs, and, importantly, the expanding sphere of nanomaterials. The topic of nanoscale materials will be developed to include approaches of organic-based systems, inorganic-based systems, and biological hybrid nanomaterials.作者: Indolent 時間: 2025-3-23 11:36 作者: expository 時間: 2025-3-23 15:20
Experimental Therapies in Breast Cancer,s in molecular-based and gene-based targeting, intralesional and intraoperative designs, and, importantly, the expanding sphere of nanomaterials. The topic of nanoscale materials will be developed to include approaches of organic-based systems, inorganic-based systems, and biological hybrid nanomaterials.作者: 撕裂皮肉 時間: 2025-3-23 20:16
0942-5373 of important emerging issues.Offers practical treatment rec.This is the first textbook of its kind devoted to describing the biological complexities of breast cancer in a way that is relevant to the radiation oncologist. Radiation Oncology has long treated breast cancer as a single biological entit作者: 全部逛商店 時間: 2025-3-23 22:16 作者: dermatomyositis 時間: 2025-3-24 06:25 作者: 有幫助 時間: 2025-3-24 07:16 作者: VICT 時間: 2025-3-24 13:55
The Destruction of a Designated Heirs remain an issue. Acknowledging the limitations in the available data, there does not appear to be any evidence of compromised normal tissue reactions or compromised long-term survival rates in women electing breast-conserving surgery and radiation.作者: 媒介 時間: 2025-3-24 18:12 作者: 種子 時間: 2025-3-24 19:21
Genetic Syndromes and Radiotherapy in Breast Cancer,s remain an issue. Acknowledging the limitations in the available data, there does not appear to be any evidence of compromised normal tissue reactions or compromised long-term survival rates in women electing breast-conserving surgery and radiation.作者: Medicaid 時間: 2025-3-25 01:43
Book 2015 cancer may interact with radiotherapy in ways that can be beneficial or undesirable.? All of these emerging issues are extensively discussed in this book, and practical evidence-based treatment recommendations are presented whenever possible. .作者: 表示問 時間: 2025-3-25 03:50
Current Clinical Role of Genetic Profiling in Breast Cancer,ssays in certain subgroups of breast cancer are ongoing. These are the Trial Assigning Individualized Options for Treatment (Rx) (TAILORx) trial, the endocrine-responsive breast cancer (RxPONDER) trial for 21-gene recurrence score and Microarray In Node-negative Disease may Avoid ChemoTherapy (MINDACT) trial using the 70-gene signature.作者: Callus 時間: 2025-3-25 10:11
Biological Subtypes of Breast Cancer, array analysis has provided insights into the dominant driver pathways that effect individual tumors and translate into clinical manifestations of the disease, response to treatment and overall clinical outcome. 作者: 食料 時間: 2025-3-25 14:45 作者: Ordnance 時間: 2025-3-25 19:31
978-3-662-52074-1Springer-Verlag Berlin Heidelberg 2015作者: medium 時間: 2025-3-25 23:45
Jonathan Strauss,William Small,Gayle E. WoloschakFirst textbook to describe the biological complexities of breast cancer in a way that is relevant to the radiation oncologist.Covers a range of important emerging issues.Offers practical treatment rec作者: 過度 時間: 2025-3-26 03:30 作者: incision 時間: 2025-3-26 06:38
https://doi.org/10.1007/978-1-4757-0878-3 array analysis has provided insights into the dominant driver pathways that effect individual tumors and translate into clinical manifestations of the disease, response to treatment and overall clinical outcome. 作者: 違法事實 時間: 2025-3-26 08:28
https://doi.org/10.1007/978-1-349-11855-7he inherent heterogeneity of the disease. There are three main subtypes which include estrogen and/or progesterone (ER/PR)-positive, epidermal growth factor receptor-2 (ErbB-2/HER2)-positive, and triple negative that lack expression of ER or PR and express wild type levels of ErbB-2. The etiology of作者: hereditary 時間: 2025-3-26 13:08
The Smallholdings and Survival, Several genetic profile assays are already commercially available, and others are being developed and tested. OncotypeDx, a 21-gene assay, and MammaPrint, a 70-gene assay are the most extensively evaluated tests. Currently, three prospective trials to assess the predictive value of gene signature a作者: output 時間: 2025-3-26 17:36 作者: 公豬 時間: 2025-3-26 21:05 作者: 有助于 時間: 2025-3-27 01:54
A Volatile Mix of Business and Politicsolymorphisms (SNPs) in many genes have been correlated to a higher risk of acute or late radiation toxicity. This chapter discusses cellular studies predictive of radiation sensitivity and studies of specific genes of interest, with a focus on breast cancer research. Radiogenomics studies of ATM, XR作者: 多嘴多舌 時間: 2025-3-27 06:11
The Destruction of a Designated Heirely recent identification of the BRCA1 and BRCA2 genes in the mid-1990s, the expense associated with testing, and the inherent selection biases, the available literature has inherent limitations with relatively small patient numbers and lack of prospective randomized trials in this subset of patient作者: 分發(fā) 時間: 2025-3-27 10:11
From Outcast to Presidential Premiertherapy is designed to maximize therapeutic potential while minimizing harm to surrounding healthy tissue. Recently, advances in material design, synthesis, and characterization have lead to a surge in the number of approaches intended to shrink or eliminate the tumor burden of breast cancer. These 作者: aristocracy 時間: 2025-3-27 17:12
Breast Cancer Biology for the Radiation Oncologist978-3-642-31220-5Series ISSN 0942-5373 Series E-ISSN 2197-4187 作者: 贊美者 時間: 2025-3-27 20:42 作者: Hemiparesis 時間: 2025-3-28 01:31
https://doi.org/10.1007/978-981-15-2833-0r pathways responsible for regulating cellular proliferation, apoptosis, and genome integrity that are altered in DCIS. We find surprisingly few differences on a genomic or gene-expression level between DCIS and invasive disease. We introduce diverse models of DCIS progression that are stochastic ve作者: 不容置疑 時間: 2025-3-28 05:27
https://doi.org/10.1007/978-981-15-2833-0 as the HER2-NFκB-HER2 signaling loop in the radioresistant BCSCs will be illustrated. Further clarification of the specific networks associated with the radioresistant phenotype of BCSCs will shed new light on the molecular mechanism of tumor radioresistance, and will help to generate targets to de作者: COM 時間: 2025-3-28 08:52 作者: growth-factor 時間: 2025-3-28 13:56 作者: 舊石器時代 時間: 2025-3-28 14:43 作者: fatty-streak 時間: 2025-3-28 21:51
0942-5373 of these emerging issues are extensively discussed in this book, and practical evidence-based treatment recommendations are presented whenever possible. .978-3-662-52074-1978-3-642-31220-5Series ISSN 0942-5373 Series E-ISSN 2197-4187
